PCgyn
ActiveSummary
PCgyn has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €202,152 and a net result of €98,073. The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
- Equity
- €202,152
- Profit
- €98,073
Why 96raises riskFounded in 2024lowers riskSize: total assets €254,092Liquidity: current ratio 4.13, cash €84,769No main activity registeredShow the evidence
Checked score
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 79% on liquidity, 90% on profitability and 92% on growth.
The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 2 accounts on average 9 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · micro…
- Liquidity more than triplescurrent ratio 4.13
- Equity above €200,000equity €202,152 ▲94.2%
Financials · financial year 2025, micro format
2024 to 2025, 2 financial years
The operating result falls in 2025; 2025 is 11% below 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Use the arrow keys on the chart for the figures per year.
Peer companies
Historical observationOf the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.9% are still going.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €9,765 | €18,143 | ▲ 85.8% |
| Other operating charges640/8 | €437 | €400 | ▼ 8.6% |
| Gross operating margin9900 | €153,949 | €146,239 | ▼ 5.0% |
| Operating profit (loss)9901 | €143,746 | €127,697 | ▼ 11.2% |
| Financial income75/76B | - | €68 | - |
| Recurring financial income75 | - | €68 | - |
| Financial charges65/66B | €1,006 | €1,654 | ▲ 64.3% |
| Recurring financial charges65 | €1,006 | €1,654 | ▲ 64.3% |
| Profit (loss) for the period before taxes9903 | €142,740 | €126,111 | ▼ 11.6% |
| Income taxes67/77 | €41,661 | €28,038 | ▼ 32.7% |
| Profit (loss) for the period9904 | €101,079 | €98,073 | ▼ 3.0% |
| Profit (loss) for the period to be appropriated9905 | €101,079 | €98,073 | ▼ 3.0% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €189,813 | €254,092 | ▲ 33.9% |
| Fixed assets21/28 | €104,873 | €86,730 | ▼ 17.3% |
| Intangible fixed assets21 | €78,464 | €66,321 | ▼ 15.5% |
| Tangible fixed assets22/27 | €14,770 | €8,770 | ▼ 40.6% |
| Furniture and vehicles24 | €14,770 | €8,770 | ▼ 40.6% |
| Financial fixed assets28 | €11,638 | €11,638 | = |
| Current assets29/58 | €84,940 | €167,362 | ▲ 97.0% |
| Amounts receivable after more than one year29 | €18,750 | €18,750 | = |
| Other amounts receivable291 | €18,750 | €18,750 | = |
| Amounts receivable within one year40/41 | €1,002 | €2,481 | ▲ 148% |
| Trade receivables40 | €1,002 | €0 | ▼ 100% |
| Other amounts receivable41 | - | €2,481 | - |
| Current investments50/53 | - | €12,000 | - |
| Cash at bank and in hand54/58 | €30,185 | €84,769 | ▲ 181% |
| Deferred charges and accrued income490/1 | €35,003 | €49,363 | ▲ 41.0% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €189,813 | €254,092 | ▲ 33.9% |
| Equity10/15 | €104,079 | €202,152 | ▲ 94.2% |
| Contributions10/11 | €3,000 | €3,000 | = |
| Reserves13 | €101,079 | €101,079 | = |
| Distributable reserves133 | €101,079 | €101,079 | = |
| Profit (loss) carried forward14 | - | €98,073 | - |
| Amounts payable17/49 | €85,733 | €51,940 | ▼ 39.4% |
| Amounts payable after more than one year17 | €15,342 | €11,457 | ▼ 25.3% |
| Financial debts170/4 | €15,342 | €11,457 | ▼ 25.3% |
| Amounts payable within one year42/48 | €70,391 | €40,483 | ▼ 42.5% |
| Current portion of amounts payable after more than one year42 | €3,744 | €3,885 | ▲ 3.8% |
| Trade debts44 | €11,094 | €3,560 | ▼ 67.9% |
| Suppliers440/4 | €11,094 | €3,560 | ▼ 67.9% |
| Taxes, remuneration and social security45 | €46,722 | €33,038 | ▼ 29.3% |
| Taxes450/3 | €44,722 | €31,038 | ▼ 30.6% |
| Remuneration and social security454/9 | €2,000 | €2,000 | = |
| Other amounts payable47/48 | €8,832 | €0 | ▼ 100% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €101,079 | €98,073 | ▼ 3.0% |
| + Depreciation and write-downs630 | €9,765 | €18,143 | ▲ 85.8% |
| Operating cash flow (approximation) | €110,845 | €116,216 | ▲ 4.8% |
| Investment in fixed assets (approximation) | - | €0 | - |
| Change in cash | - | €54,584 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (2)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 22-07-2026 | 2026-00316922 |
| 31-12-2024 | micro format | 26-08-2025 | 2025-00402962 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| CRUTZEN Pauline Béatrice |
|
Owners and capital
Capital and shareholders
- CRUTZEN Pauline Béatrice 100 shares (100%) · €3,000
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 20-06-2024 Incorporation · €3,000 · 100 shares
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
Acts, filings and financial milestones
20-06
Gazette deed
IncorporationAppointment: CRUTZEN Pauline Béatrice (director) · Founder · Founding capital10 facts ▸
- Incorporation, “PCgyn” (deed in French)
- Founder, CRUTZEN Pauline Béatrice
- Founding capital, €3,000
- Other provision, 01-04-2024
- Other provision, “responsabilité des fondateurs, faillite de la société dans les trois ans de sa constitution” (deed in French)
- Other provision, “demande de dressement des statuts, a requis de dresser les statuts” (deed in French)
- Capital
- Registered office clause, “4802 Verviers, Avenue de Thiervaux”, 90, “à dater du jour où société acquerra personnalité morale” (deed in French)
- Director appointment, CRUTZEN Pauline Béatrice (director (not named in the articles))
- Pre-incorporation commitments, “takeover, tous engagements,obligations et activités entrepris par comparante au nom et pour compte société en formation” (deed in French)
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 31 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 63572C0157/00G007 | Wallonia | 497 m² | 1 · 104 m² | 9.3 m · 2 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “La société a pour objet l'exercice de la médecine, et plus particulièrement dans les domaines de la gynécologie, par le ou les actionnaires…” (deed in French)
7 activities (deed in French)
- La société a pour objet l'exercice de la médecine, et plus particulièrement dans les domaines de la gynécologie, par le ou les actionnaires qui la composent, lesquels sont exclusivement des médecins inscrits au Tableau de l'Ordre des Médecins ou des sociétés de médecins à personnalité juridique dont les statuts ont été approuvés par le Conseil de l’Ordre des Médecins.
- La médecine est exercée au nom et pour le compte de la société. En cas de pluralité d’actionnaires, ceux-ci mettent en commun la totalité de leur activité médicale au sein de la société.
- Les honoraires sont perçus par et pour la société.
- La société a pour but de leur permettre de pratiquer une médecine de qualité, dans le respect de la déontologie et de la liberté thérapeutique et diagnostique, de la dignité et de l'indépendance professionnelle par l'amélioration et la rationalisation de leur équipement professionnel.
- D'une manière générale, la société peut exercer toute activité susceptible de favoriser la réalisation de son objet et s'intéresser par toutes voies dans toutes entreprises ayant un but identique, analogue ou connexe ou qui est de nature à favoriser le développement de sa propre activité.
- La société pourra d'une façon générale accomplir toutes les opérations financières, mobilières ou immobilières pour autant que celles-ci ne présentent pas un caractère commercial et de ce fait incompatible avec l’objet de la société.
- A titre accessoire, la société pourra également avoir pour objet la constitution, la gestion et la valorisation d’un patrimoine mobilier ou immobilier, notamment par l’achat, la vente, la location, la mise en location, la construction, le tout au sens large, pour autant que n’en soit pas altéré sa vocation médicale et que ces opérations s’inscrivant dans les limites d’une gestion par une personne prudente et raisonnable n’aient pas un caractère répétitif.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- PCgyn
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région wallonne, transfert en tout endroit de la Région de Bruxelles-Capitale ou de la région de langue française de Belgique par simple…” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Avec ou sans limitation de durée,statutaire si nommés dans statuts, un ou plusieurs administrateurs,personnes physiques ou…” (deed in French)“Fixe ou proportionnelle portée aux frais généraux, frais représentation,voyages et déplacements en sus” (deed in French)“1, assemblée” (deed in French)
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Nominatives, registre des actions nominatives avec mentions requises par le Code des sociétés et des associations” (deed in French)
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Prochaine Assemblée Générale Ordinaire ou Extraordinaire, héritiers et légataires tenus de solliciter agrément mêmes formes,délais et…” (deed in French)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- 6 May at 17:00
Oversight and winding up
- Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Prévues pour modifications aux statuts, assemblée générale” (deed in French)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Administrateurs médecins en fonction désignés liquidateur(s) en vertu des statuts, si aucun autre liquidateur désigné” (deed in French)